Form 8-K - Current report:
SEC Accession No. 0001193805-21-000256
Filing Date
2021-02-22
Accepted
2021-02-22 17:00:32
Documents
13
Period of Report
2021-02-17
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620313_8k-arct.htm   iXBRL 8-K 24780
2 e620313_ex99-1.htm EX-99.1 7399
  Complete submission text file 0001193805-21-000256.txt   209581

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arct-20210217.xsd EX-101.SCH 3193
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20210217_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20210217_pre.xml EX-101.PRE 22715
6 EXTRACTED XBRL INSTANCE DOCUMENT e620313_8k-arct_htm.xml XML 3632
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 21661148
SIC: 2834 Pharmaceutical Preparations